Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score AnalysisFélix Ackermann, Marie-Alice Colombier, Éric Farfour et al.|Journal of Clinical Immunology|2020Cited by 53
The ID NOW COVID-19, a high-speed high-performance assayÉric Farfour, C Amiel, Marianne Asso‐Bonnet et al.|European Journal of Clinical Microbiology & Infectious Diseases|2021Cited by 16
Determinants of radiological patterns and severity in immunocompromised adults with Metapneumovirus infectionAishah Abdulrahman Al-Hamoud, Olivier Lortholary, Nathalie Pansu et al.|Respiratory Medicine|2024Cited by 5
Tocilizumab to Prevent Ventilatory Support for Severe Worsening COVID-19 Pneumonia: A Propensity Score AnalysisMathilde Roumier, Félix Ackermann, Romain Paule et al.|SSRN Electronic Journal|2020Cited by 1
Infection respiratoire à métapneumovirus chez le patient immunodépriméA. Al Hamoud, O. Lortholary, N. Pansu et al.|Revue des Maladies Respiratoires Actualités|2021Cited by 0